ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $884 | -15.7% | 1,133,775 | 0.0% | 0.04% | +15.2% |
| Q2 2023 | $1,049 | -100.0% | 1,133,775 | +62.0% | 0.03% | -53.5% |
| Q4 2017 | $4,676,000 | +14.2% | 700,000 | +40.0% | 0.07% | 0.0% |
| Q3 2017 | $4,095,000 | +204.0% | 500,000 | +66.7% | 0.07% | +195.8% |
| Q2 2017 | $1,347,000 | -18.5% | 300,000 | 0.0% | 0.02% | -35.1% |
| Q1 2017 | $1,653,000 | +36.0% | 300,000 | 0.0% | 0.04% | +37.0% |
| Q4 2016 | $1,215,000 | -13.8% | 300,000 | +50.0% | 0.03% | -3.6% |
| Q3 2016 | $1,410,000 | – | 200,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $2,341,000 | 3.33% |
| Matrix Capital Management Company, LP | 38,974,185 | $66,256,000 | 1.50% |
| NEA Management Company, LLC | 17,082,612 | $29,040,000 | 1.49% |
| Endurant Capital Management LP | 1,824,065 | $3,101,000 | 1.09% |
| Long Focus Capital Management, LLC | 4,679,491 | $7,955,000 | 0.83% |
| Key Client Fiduciary Advisors, LLC | 416,166 | $707,000 | 0.69% |
| PFM Health Sciences, LP | 9,109,780 | $15,487,000 | 0.59% |
| ACT CAPITAL MANAGEMENT, LLC | 90,000 | $153,000 | 0.21% |
| DAFNA Capital Management LLC | 351,064 | $597,000 | 0.16% |
| Rock Springs Capital Management LP | 2,357,544 | $4,008,000 | 0.12% |